As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Abbott Laboratories: Hudson Bay Capital Management LP, Nomura Holdings Inc., Man Group plc, LMR Partners LLP, Hudson Bay Capital Management LP, Group One Trading LLC, Cubist Systematic Strategies LLC, BNP Paribas Financial Markets, Balyasny Asset Management L.P., Bank of America Corp DE, Jane Street Group LLC, Squarepoint Ops LLC, Qube Research & Technologies Ltd, Maven Securities LTD, Capula Management Ltd, Walleye Capital LLC, Walleye Trading LLC, Lido Advisors LLC, Delta Accumulation LLC, Capital Fund Management S.A., Eisler Capital Management Ltd., JPMorgan Chase & Co., Citigroup Inc., Creative Planning, Garda Capital Partners LP, Simplex Trading LLC, Bank of Montreal Can, Wolverine Asset Management LLC, and Allianz Asset Management GmbH. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.